| DTT Name |
H-ras messenger RNA (HRAS mRNA)
|
| Synonyms |
p21ras (mRNA); cHras (mRNA); c-H-ras (mRNA); Transforming protein p21 (mRNA); HaRas (mRNA); Ha-Ras (mRNA); H-Ras-1 (mRNA); GTPase HRas, Nterminally processed (mRNA); GTPase HRas (mRNA) |
| Gene Name |
HRAS
|
| DTT Type |
Discontinued target
|
[1] |
| BioChemical Class |
mRNA target
|
| UniProt ID |
|
| TTD ID |
|
| 3D Structure |
|
| Sequence |
MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAG
QEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDL
AARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQHKLRKLNPPDESGPG
CMSCKCVLS
|
| Function |
Ras proteins bind GDP/GTP and possess intrinsic GTPase activity. Involved in the activation of Ras protein signal transduction. |
| KEGG Pathway |
- MAPK signaling pathway (hsa04010 )
- ErbB signaling pathway (hsa04012 )
- Ras signaling pathway (hsa04014 )
- Rap1 signaling pathway (hsa04015 )
- Chemokine signaling pathway (hsa04062 )
- FoxO signaling pathway (hsa04068 )
- Sphingolipid signaling pathway (hsa04071 )
- Endocytosis (hsa04144 )
- PI3K-Akt signaling pathway (hsa04151 )
- Axon guidance (hsa04360 )
- VEGF signaling pathway (hsa04370 )
- Focal adhesion (hsa04510 )
- Tight junction (hsa04530 )
- Gap junction (hsa04540 )
- Signaling pathways regulating pluripotency of stem cells (hsa04550 )
- Natural killer cell mediated cytotoxicity (hsa04650 )
- T cell receptor signaling pathway (hsa04660 )
- B cell receptor signaling pathway (hsa04662 )
- Fc epsilon RI signaling pathway (hsa04664 )
- Long-term potentiation (hsa04720 )
- Neurotrophin signaling pathway (hsa04722 )
- Cholinergic synapse (hsa04725 )
- Serotonergic synapse (hsa04726 )
- Long-term depression (hsa04730 )
- Regulation of actin cytoskeleton (hsa04810 )
- Insulin signaling pathway (hsa04910 )
- GnRH signaling pathway (hsa04912 )
- Estrogen signaling pathway (hsa04915 )
- Melanogenesis (hsa04916 )
- Prolactin signaling pathway (hsa04917 )
- Thyroid hormone signaling pathway (hsa04919 )
- Oxytocin signaling pathway (hsa04921 )
- Alcoholism (hsa05034 )
- Hepatitis C (hsa05160 )
- Hepatitis B (hsa05161 )
- HTLV-I infection (hsa05166 )
- Pathways in cancer (hsa05200 )
- Viral carcinogenesis (hsa05203 )
- Proteoglycans in cancer (hsa05205 )
- MicroRNAs in cancer (hsa05206 )
- Renal cell carcinoma (hsa05211 )
- Endometrial cancer (hsa05213 )
- Glioma (hsa05214 )
- Prostate cancer (hsa05215 )
- Thyroid cancer (hsa05216 )
- Melanoma (hsa05218 )
- Bladder cancer (hsa05219 )
- Chronic myeloid leukemia (hsa05220 )
- Acute myeloid leukemia (hsa05221 )
- Non-small cell lung cancer (hsa05223 )
- Central carbon metabolism in cancer (hsa05230 )
- Choline metabolism in cancer (hsa05231 )
|
| Reactome Pathway |
- Activation of RAS in B cells (R-HSA-1169092 )
- Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants (R-HSA-1236382 )
- SHC1 events in ERBB2 signaling (R-HSA-1250196 )
- SHC1 events in ERBB4 signaling (R-HSA-1250347 )
- p38MAPK events (R-HSA-171007 )
- GRB2 events in EGFR signaling (R-HSA-179812 )
- SHC1 events in EGFR signaling (R-HSA-180336 )
- GRB2 events in ERBB2 signaling (R-HSA-1963640 )
- Tie2 Signaling (R-HSA-210993 )
- EGFR Transactivation by Gastrin (R-HSA-2179392 )
- DAP12 signaling (R-HSA-2424491 )
- SHC-related events triggered by IGF1R (R-HSA-2428933 )
- FCERI mediated MAPK activation (R-HSA-2871796 )
- NCAM signaling for neurite out-growth (R-HSA-375165 )
- EPHB-mediated forward signaling (R-HSA-3928662 )
- Ras activation uopn Ca2+ infux through NMDA receptor (R-HSA-442982 )
- VEGFR2 mediated cell proliferation (R-HSA-5218921 )
- CD209 (DC-SIGN) signaling (R-HSA-5621575 )
- Constitutive Signaling by EGFRvIII (R-HSA-5637810 )
- SHC-mediated cascade (R-HSA-5654688 )
- FRS-mediated FGFR1 signaling (R-HSA-5654693 )
- SHC-mediated cascade (R-HSA-5654699 )
- FRS-mediated FGFR2 signaling (R-HSA-5654700 )
- SHC-mediated cascade (R-HSA-5654704 )
- FRS-mediated FGFR3 signaling (R-HSA-5654706 )
- FRS-mediated FGFR4 signaling (R-HSA-5654712 )
- SHC-mediated cascade (R-HSA-5654719 )
- Regulation of RAS by GAPs (R-HSA-5658442 )
- RAF activation (R-HSA-5673000 )
- RAF/MAP kinase cascade (R-HSA-5673001 )
- MAP2K and MAPK activation (R-HSA-5674135 )
- Negative regulation of MAPK pathway (R-HSA-5675221 )
- Insulin receptor signalling cascade (R-HSA-74751 )
- SOS-mediated signalling (R-HSA-112412 )
|
|
|
|
|
|
|
